(2S)-2-AMINO-2-(3,4-DIFLUOROPHENYL)ACETIC ACID, 95.0%, 500mg

5-Isobutyl-1H-pyrazole-3-carboxylic acid, 95.0%, 2.5g

1-([1,2,4]triazolo[4,3-a]pyridin-7-yl)ethanamine, 97%, 1g

4-Ethynylthiophene-2-carbaldehyde, 97%, 250mg

tert-Butyl-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-carbamate, 97.0%, 1g

(3R,4S)-4-Aminooxolan-3-ol, 98%, 500mg

Methyl 3-Bromoisonicotinate>98.0%(GC)1g

8-Chloroimidazo[1,2-a]pyridine, 95.0%, 25g

1-(2-(TRIFLUOROMETHYL)PHENYL)CYCLOBUTANECARBOXYLIC ACID, 95.0%, 250mg

4-(Ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid, 95.0%, 5g

TERT-BUTYL 3-OXO-1-OXA-6-AZASPIRO[3.3]HEPTANE-6-CARBOXYLATE, 95.0%, 100mg

4-Fluoro-2'-(trifluoromethyl)-[1,1'-biphenyl]-3-carboxylic acid, 95.0%, 1g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 150, 4000 ml, 190 mm, 1 Piece